Our Chief Executive, Catherine Woodhead, has announced she will be leaving the charity this year. Catherine joined Muscular Dystrophy UK in 2016 as Director of Development and became Chief Executive in 2018.

Under Catherine’s leadership, Muscular Dystrophy UK has invested more in research, laid the foundations for potential new treatments, secured NHS investment in specialist neuromuscular services, and supported more people across the UK. We’re extremely grateful to Catherine for her dedication and vision, which has ensured we are in a strong position as we look to the future.

We’re delighted to announce, thanks to our partnership with LifeArc and the Lily Foundation, the establishment of a new research centre, giving hope to thousands of people living with rare mitochondrial diseases.

We’ve been awarded the PIF TICK – the UK’s only assessed quality mark for print and online health and care information.